Cargando…
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
Multiple sclerosis (MS) is an autoimmune disease of unknown cause, in which chronic inflammation drives multifocal demyelination of axons in both white and gray matter in the CNS. The pathological course of the disease is heterogeneous and involves an early, predominantly inflammatory demyelinating...
Autores principales: | Harris, Violaine K., Sadiq, Saud A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245485/ https://www.ncbi.nlm.nih.gov/pubmed/25164543 http://dx.doi.org/10.1007/s40291-014-0117-0 |
Ejemplares similares
-
Biomarkers of multiple sclerosis: current findings
por: Harris, Violaine K, et al.
Publicado: (2017) -
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis
por: Harris, Violaine K., et al.
Publicado: (2023) -
Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
por: Chen, Shyi-Jou, et al.
Publicado: (2012) -
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis
por: Mir, Fozia, et al.
Publicado: (2014) -
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
por: Harris, Violaine K., et al.
Publicado: (2018)